LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
NC Global Advantage Forum
Event | 11. 10. 2022
Karent LeVert will be speaking at the NC Global Advantage Forum on the impact of climate change on agriculture and how North Carolina's growing AgTech prowess can make a global impact.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.